Mylan receives FDA approval for generic version of heartburn drug Prevacid
Associated Press
11/10/09 4:00 PM EST
PITTSBURGH — Mylan Inc. said Tuesday the Food and Drug Administration approved its generic version of the heartburn drug Prevacid.
Mylan will sell 15-milligram and 30-milligram delayed-release capsule versions of the drug.
Mylan said the branded version of Prevacid had sales of about $3 billion in the 12 months ending June 30.
Shares of Mylan fell 32 cents to $17.59 in afternoon trading.


